Previous close | 46.16 |
Open | 46.04 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's range | 45.80 - 46.33 |
52-week range | 43.25 - 89.70 |
Volume | |
Avg. volume | 5,328,880 |
Market cap | 23.19B |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | 23.00 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.16 (2.51%) |
Ex-dividend date | 01 Dec 2022 |
1y target est | N/A |
Buy low, sell high. Those four words can make fortunes over time. And they work whether we're talking about real estate, stocks, or any other asset. The great thing about investing in some stocks when they're down is that they pay you to wait for a rebound via dividends.
Baxter (BAX) plans several strategic actions, including spin-off of Renal Care and Acute Therapies global business units into an independent, publicly traded company to simplify its operating model.